These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 5306592

  • 1. [Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
    Carratù L, Sonaglioni F, Natali P.
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):399-410. PubMed ID: 5306592
    [No Abstract] [Full Text] [Related]

  • 2. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F, Centrella G, Stefanelli R.
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 4. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G, Lévy A, Guignon JP, Lecoq H, Friess JM, Maman P.
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract] [Full Text] [Related]

  • 5. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E.
    Dtsch Med Wochenschr; 1970 Jan 16; 95(3):139-41. PubMed ID: 5411222
    [No Abstract] [Full Text] [Related]

  • 6. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1969 Jan 16; 69():43-53. PubMed ID: 4906373
    [No Abstract] [Full Text] [Related]

  • 7. [New drugs in antitubercular therapy].
    Favez G.
    Helv Med Acta Suppl; 1969 Jan 16; 49():66-80. PubMed ID: 4912509
    [No Abstract] [Full Text] [Related]

  • 8. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V, Niederkofler J.
    Wien Med Wochenschr; 1970 Jun 20; 120(25):473-5. PubMed ID: 5518004
    [No Abstract] [Full Text] [Related]

  • 9. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
    Shukiurov ShZ.
    Probl Tuberk; 1973 Jun 20; 51(12):40-3. PubMed ID: 4782102
    [No Abstract] [Full Text] [Related]

  • 10. [Recent drugs in the treatment of primary tuberculosis].
    Gerbeaux J, Hanoteau J.
    Rev Tuberc Pneumol (Paris); 1971 Jun 20; 35(3):315-25. PubMed ID: 5315164
    [No Abstract] [Full Text] [Related]

  • 11. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J, Marécaux L.
    Rev Tuberc Pneumol (Paris); 1969 Mar 20; 33(2):226-41. PubMed ID: 5385585
    [No Abstract] [Full Text] [Related]

  • 12. [The therapeutic activity of rifampycin in chronic states of pulmonary tuberculosis].
    Bariffi F, Di Filippo A, Marinelli M.
    Arch Tisiol Mal Appar Respir; 1968 May 20; 23(5):355-76. PubMed ID: 5306590
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C, Cornia G, Cirianni C, Garimoldi M, Ginesu F, Mandler F, Perna G, Pradella F.
    G Ital Chemioter; 1968 May 20; 15(4):92-4. PubMed ID: 5744843
    [No Abstract] [Full Text] [Related]

  • 14. New drugs against tuberculosis.
    Lancet; 1969 May 31; 1(7605):1081-2. PubMed ID: 4181738
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF, Sagalovich VIa.
    Probl Tuberk; 1974 May 31; (12):26-30. PubMed ID: 4445131
    [No Abstract] [Full Text] [Related]

  • 16. [Condition of the liver in patients with chronic pulmonary tuberculosis receiving a combination of antibacterial drugs including rifampicin and ethambutol].
    Kondrat'eva VI, Umarova MK, Arifkhanova SI.
    Probl Tuberk; 1977 May 31; (2):35-40. PubMed ID: 866309
    [No Abstract] [Full Text] [Related]

  • 17. [Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
    Boccitto G, Sbampato M, Sternini N.
    Ann Ist Carlo Forlanini; 1968 May 31; 28(2):126-41. PubMed ID: 5735705
    [No Abstract] [Full Text] [Related]

  • 18. Drugs in the treatment of tuberculosis--1969.
    Beacham EG.
    Johns Hopkins Med J; 1969 Nov 31; 125(5):286-90. PubMed ID: 5366128
    [No Abstract] [Full Text] [Related]

  • 19. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E, Azevedo DE, Sayeg F.
    Rev Bras Med; 1971 Apr 31; 28(4):171-9. PubMed ID: 5120854
    [No Abstract] [Full Text] [Related]

  • 20. [Modern tuberculosis therapy].
    Krohn J.
    Tidsskr Nor Laegeforen; 1973 Dec 30; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.